T&R biofab
3D Printing Financials: How T&R BioFab is Balancing Innovation and Revenue Challenges
South Korean bioprinting pioneer T&R Biofab (Kosdaq: 246710) has been busy in recent months with new initiatives in regenerative medicine, collaborations, and product development. However, the company faces significant challenges…
World’s First Bioprinted Trachea Transplant Marks a New Era in Medical Innovation
A research team from the Catholic University of Korea has successfully implanted the world’s first bioprinted artificial trachea into a patient, customized using adult stem cells from another person. Led…
The Rise of 3D Printing in South Korea
South Korea has been steadily increasing its involvement in additive manufacturing (AM), particularly in the post-2010s, with the government’s “Manufacturing Innovation 3.0” strategy placing AM at the forefront. This initiative,…
Korean Food Giant Taps T&R Biofab to Bioprint New Plant-Based Meats
South Korean food behemoth CJ CheilJedang has joined forces with bioprinting expert T&R Biofab (Kosdaq: 246710), signaling a game-changing merger of food production and cutting-edge 3D bioprinting technology. This collaboration…
3D Printing News Briefs, August 7, 2021: Metal 3D Printer, 3D Printed Bridge, & More
In today’s 3D Printing News Briefs, we’re discussing a new 3D printer from Ace Micromatic Group, and moving on to medical 3D printing news out of T&R Biofab and Tsunami…
South Korea: T&R Biofab Will Use 3D Cell Bioprinting Technology for New Stem Cell Research
One of the leading South Korean biomedical engineering companies has been selected by the Ministry of Health and Welfare of that country to develop cell maturation technology for pluripotent stem…
3D Printing: The Stories We Missed This Week — September 3, 2016
From major business acquisitions to exploding rockets, it’s been quite a wild and bumpy ride into the weekend. Here’s a look back at some of the news that we didn’t manage…
